Skip to content

Omnicell OMCL Increase (Decrease) in Other Current Assets

Increase (Decrease) in Other Current Assets at other companies

Guardian Pharmacy Services logo
Guardian Pharmacy ServicesGRDN

Other financials

Income statement

See full
Revenue$309.9M+14.9%
Gross profit$140.4M+26.5%
Operating income$16.9M+245%
Net income$11.4M+262%
EPS (diluted)$0.25+267%

Balance sheet

See full
Cash & equivalents$291.0M-29.8%
Total debt$34.3M-23.1%
Total equity$1.3B0.0%
Total assets$2.0B-6.8%

Cash flow

See full
Operating cash flow$54.5M+110%
CapEx$12.4M+11.3%
Free cash flow$42.1M+185%

Valuation

See full
Market cap$1.75B-7.2%
Enterprise value$1.49B-0.4%
P/E113.2×
P/S1.4×-0.2×

Profitability

See full
Gross margin43.5%+0.4pp
Operating margin2.7%+1.8pp
Net margin1.7%+1.1pp
FCF margin9.3%-1.7pp

Returns & leverage

See full
Return on equity1.6%+1.1pp
Debt / equity0.0×
Current ratio1.5×+0.1×

Where this comes from

Reported directly by Omnicell in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherCurrentAssets.

The official record: Omnicell’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Omnicell's increase (decrease) in other current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Omnicell's increase (decrease) in other current assets?
Omnicell (OMCL) reported increase (decrease) in other current assets of $4.87M in Q1 2026.
How has Omnicell's increase (decrease) in other current assets changed year-over-year?
Omnicell's increase (decrease) in other current assets increased by 43.1% year-over-year, from $3.4M to $4.87M.
What is the long-term trend for Omnicell's increase (decrease) in other current assets?
Over 2 years (2022 to 2024), Omnicell's increase (decrease) in other current assets has grown at a 18.1% compound annual growth rate (CAGR), from -$6.69M to -$9.34M.